...
首页> 外文期刊>Clinical Biochemistry >Identification of novel and rare CYP21A2 variants in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
【24h】

Identification of novel and rare CYP21A2 variants in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

机译:由于21-羟化酶缺乏,中国先天性肾上腺增生患者鉴定新型和罕见的CYP21A2变体

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: 21-hydroxylase deficiency (21-OHD) is the most common cause of congenital adrenal hyperplasia due to CYP21A2 gene mutation. The aim of study is to expand CYP21A2 mutational spectrum in the Chinese population and to provide novel genetic information in terms of ethnic diversity. Design and methods: 95 Chinese suspected 21-OHD patients with phenotypes varying from salt-wasting (SW) to nonclassic symptoms were recruited. The clinical characteristics were retrospectively analyzed. Sanger sequencing and multiplex ligation-depcndent probe amplification were used to detect point mutations and large gene deletions, respectively. Results: 20 different mutant alleles were detected in 35 patients with 21-OHD. The most common variant was C.293-13A/C >G (30.0%), followed by p.I173N (20.0%), large gene conversions (14.3%), large gene deletions (11.4%), and p.R484Pfs*58 (4.3%). Remarkably, we identified a novel F450L variant, in silico predicted to be associated with the salt-wasting form. Two variants including p.R409C and p.R427H, previously considered as conserved in specific ethnicities due to a founder effect, were detected in our cohort. Further, a rare p.H63L + p.V70L variant, hitherto only observed in the Chinese population, in trans with different variants corresponding to the salt-wasting form resulted in diverse phenotypes. Conclusions: One novel and four rare variants of CYP21A2 gene corresponding to severe phenotypes were identified in our cohort. Two variants including p.R409C and p.R427H have wider ethnic distributions. Therefore, the sequence of CYP21A2 gene must be analyzed carefully in case rare or novel deleterious variants exist. Our findings improve the understanding of CYP21A2 mutational spectrum in 21-OHD patients and contribute to the precise diagnosis and prenatal counseling.
机译:目的:21-羟化酶缺乏(21-OHD)是由于CYP21A2基因突变引起的先天性肾上腺增生的原因。研究的目的是扩大中国人口中的CYP21A2突变谱,并在种族多样性方面提供新的遗传信息。设计与方法:95例中国涉嫌21-OHD患者,从盐浪费(SW)变为非植染症状的表型患者。回顾性分析了临床特征。 Sanger测序和多重连接 - Depcndent探针扩增分别用于检测点突变和大型基因缺失。结果:在35例21小时患者中检测到20种不同的突变等位基因。最常见的变体是C.293-13A / C> G(30.0%),其次是P.I173N(20.0%),大基因转化(14.3%),大型基因缺失(11.4%)和P.R484PFS * 58(4.3%)。值得注意的是,我们鉴定了一种新型F450L变体,在预测与盐浪费形式相关的硅中。在我们的队列中检测到包括P.R409C和P.R427H,包括P.R409C和P.R427H,以前被认为是由于创始效应而在特定的种族中保守。此外,仅在中国人群中观察到罕见的p.H63L + P.V70L变体,其具有与盐浪费形式相对应的不同变体导致不同的表型。结论:在我们的队列中鉴定了对应于严重表型的CYP21A2基因的一种新颖和四种稀有变体。包括P.R409C和P.R427H在内的两种变体具有更广泛的民族分布。因此,在存在稀有或新颖的有害变体的情况下,必须小心地分析CYP21A2基因序列。我们的研究结果提高了21欧姆患者CYP21A2突变谱的理解,并有助于精确的诊断和产前咨询。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号